Neurology and Neurosurgery

193-208 of 455

Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiers
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
- Amber Salter, PhD
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiers
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
- Michael Kornberg, MD, PhD
Managing Multiple Sclerosis: The Impact of Dietary Modifications
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple Sclerosis
Managing Multiple Sclerosis: The Impact of Dietary Modifications
- Charles Turck, PharmD, BCPS, BCCCP
- Anna A. Shah, MD
Strategies and Considerations for Managing MS in Pregnant Women
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple Sclerosis
Strategies and Considerations for Managing MS in Pregnant Women
- Charles Turck, PharmD, BCPS, BCCCP
- Anna A. Shah, MD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
- Christopher Lock, MD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiers
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
- Dalia Rotstein, MD, MPH
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiers
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
- Cristin Welle, PhD
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
- Amy Kuceyeski, PhD
Multiple Sclerosis Explained: Understanding Its Epidemiology
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
- Jonathan E. Howard, MD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
- Maxwell H. Levy, MD
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
- David Kimhy, PhD
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple Sclerosis
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
- Marisa McGinley, DO
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
- Aaron Besterman, MD
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiers
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
- Natalie Bareis, PhD, LMSW
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
On the Frontlines of Multiple Sclerosis
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
- Glenn Wylie, DPhil

13/11

Neurology and Neurosurgery

193-208 of 455

NEED HELP?

Contact us

NEED HELP?

Contact us

193-208 of 455

Title

Share on ReachMD